VIII. NEURODEGENERATIVE DISEASES

24
VIII. NEURODEGENERATIVE DISEASES

description

VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function, rather than by physical location in the brain. - PowerPoint PPT Presentation

Transcript of VIII. NEURODEGENERATIVE DISEASES

Page 1: VIII. NEURODEGENERATIVE DISEASES

VIII. NEURODEGENERATIVE DISEASES

Page 2: VIII. NEURODEGENERATIVE DISEASES

- Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function, rather than by physical location in the brain.

- Many of these disorders are associated with the accumulation of abnormal proteins, which serve as histologic hallmarks of specific disorders

- An important but unanswered question is why these abnormal proteins tend to affect particular neurons

Page 3: VIII. NEURODEGENERATIVE DISEASES

, since the involved proteins are widely expressed throughout the nervous system

- The possible explanation that subtle differences among subtypes of neurons are presumed to explain why particular neurons are affected in specific disorders.

- The clinical manifestations of degenerative diseases are dictated by the pattern of neuronal dysfunction:

Page 4: VIII. NEURODEGENERATIVE DISEASES

A. Those affect the cortical neurons result in dementia;

B. Those affect basal ganglia neurons result in movement disorders

C. Those that affect the cerebellum result in ataxiaNote: Although many degenerative diseases have

primary targets, other brain regions are often affected later in the course of the illness

Page 5: VIII. NEURODEGENERATIVE DISEASES

Dementia := is defined as the development of memory

impairment and other cognitive deficits severe enough to decrease the affected person's capacity to function at the previous level despite a normal level of consciousness.

- It arises during the course of many neurodegenerative diseases; but it also accompany other diseases that injure the cerebral cortex such as:

Page 6: VIII. NEURODEGENERATIVE DISEASES

1. Infectionsa. Prion disease & neurosyphilisb. HIV associated neurocognitive disorderc. Chronic meningitis2. Vascular and traumatic diseasesa. Multifocal cerebral infarctionb. b. Chronic traumatic encephalopathy

Page 7: VIII. NEURODEGENERATIVE DISEASES

3. Metabolic and nutritional diseases- Thiamine , Vit B12 and Niacin deficiencies4. Miscellaneous such as toxicity from lead and

manganese

Page 8: VIII. NEURODEGENERATIVE DISEASES

I. Alzheimer Disease (AD)- Is the most common cause of dementia in the

elderly population manifests with the insidious onset of impaired higher intellectual function, altered mood and behavior.

- Later, this progresses to disorientation, memory loss, and aphasia, findings indicative of severe cortical dysfunction,

- And over another 5 to 10 years, the patient becomes profoundly disabled, mute, and immobile.

Page 9: VIII. NEURODEGENERATIVE DISEASES

- Death usually occurs from intercurrent pneumonia - Age is an important risk factor for AD;a. The incidence is 3% in persons 65 to 74 years old, b. 9% in 75 to 84 years old to 47% in those older than

84 - Most cases of AD are sporadic - 5% to 10% are familial. • Sporadic cases rarely present before 50 years of

age, but early onset is seen with some heritable forms

Page 10: VIII. NEURODEGENERATIVE DISEASES

PATHOGENESIS :- Study of the familial forms of AD supports a model

in which Aβ amyloid, accumulates in the brain over time, initiating a chain of events that result in AD.

1- Aβ is created when the transmembrane protein amyloid precursor protein (APP) is sequentially cleaved by the enzymes β-amyloid converting enzyme (BACE) and γ-secretase

- APP also can be cleaved α-secretase and γ-secretase, which liberates a different peptide that is nonpathogenic

Page 11: VIII. NEURODEGENERATIVE DISEASES

Aβ peptide genesis and consequences in AD

Page 12: VIII. NEURODEGENERATIVE DISEASES

.How deposits of Aβ cause manifestation 1. While large deposits are a feature of end-stage

AD, small aggregates of Aβ may also be pathogenic, as

a. They alter neurotransmission and areb. Toxic to neurons and synaptic endings found in

the superficial cerebral cortex,

Page 13: VIII. NEURODEGENERATIVE DISEASES

Large deposits, in the form of plaques,:1. elicite a local inflammatory response Lead to

neuronal death 2. And may cause altered region-to-region

communication through mechanical effects on axons and dendrites.

Page 14: VIII. NEURODEGENERATIVE DISEASES

3. Aβ amyloid also leads to hyperphosphorylation of the neuronal microtubule binding protein tau and this increased level of phosphorylation causes tau to redistribute from axons into dendrites and cell bodies, where it aggregates into tangles, which also contribute to neuronal dysfunction and cell death.

Page 15: VIII. NEURODEGENERATIVE DISEASES

Familial forms1. Mutations in APP or in components of γ-secretase

(presenilin-1 or presenilin-2) lead to familial AD by increasing the rate at which Aβ is generated.

2. The APP gene is located on chromosome 21, - The risk of AD is higher in Down syndrome: an

extra copy of the APP gene, is present in patients with trisomy 21

Page 16: VIII. NEURODEGENERATIVE DISEASES

3. The other major genetic risk factor is a variant of apolipoprotein E called Εε4 (ApoE ε 4).

- Each ApoE ε 4 allele that is present increases the risk of AD by approximately 4 fold and also appears to lower the age of onset.

- How ApoE ε 4 influences Aβ accumulation is unknown;

a. It may increase Aβ aggregation or deposition,b. Or decrease Aβ clearance

Page 17: VIII. NEURODEGENERATIVE DISEASES

Macroscopic examination of the brain1. Variable degree of cortical atrophy, most severe in

the frontal, temporal, and parietal lobes. 2. With significant atrophy, there is compensatory

ventricular enlargement (hydrocephalus ex vacuo). At the microscopic level, AD is diagnosed by the

presence 1. Of Amyloid plaques (an extracellular lesion) 2. And neurofibrillary tangles (an intracellular lesion)

Page 18: VIII. NEURODEGENERATIVE DISEASES

. Note:- These lesions may also be present to a lesser

extent in the brains of elderly non-demented persons, so the current criteria for a diagnosis of AD are based on a combination of clinical and pathologic features.

- There is a fairly constant progressive involvement of different parts of the brain.:

Page 19: VIII. NEURODEGENERATIVE DISEASES

Pathologic features of AD

Page 20: VIII. NEURODEGENERATIVE DISEASES

Pathologic changes (specifically plaques, tangles, and the associated neuronal loss and glial reaction)

a. Are evident first in the entorhinal cortex b. Then in the hippocampal formation, c. And finally in the neocortex.

Page 21: VIII. NEURODEGENERATIVE DISEASES

1. Neuritic plaques : - Are focal, spherical collections of dilated,

tortuous, silver-staining neuritic processes (dystrophic neurites), often around a central amyloid core

- Range in size from 20 to 200 μm in diameter - Plaques can be found in the hippocampus and

amygdala as well as in the neocortex

Page 22: VIII. NEURODEGENERATIVE DISEASES

- There usually is relative sparing of primary motor and sensory cortices until late in the disease course.

2. Diffuse plaques: - Are Aβ deposits lacking the surrounding neuritic

reaction, typically are found in the superficial cerbral cortex, basal ganglia , and the cerebellar cortex

Page 23: VIII. NEURODEGENERATIVE DISEASES

2..Neurofibrillary tangles :- Are bundles of paired helical filaments visible as

basophilic in the cytoplasm of the neurons that displace or encircle the nucleus;

- Tangles can persist after neurons die, becoming a form of extracellular pathology and are commonly found in:

Page 24: VIII. NEURODEGENERATIVE DISEASES

a. In the entorhinal cortex,b. In pyramidal cells of the hippocampus and

amygdala, c. The basal forebrain, and the raphe nuclei. - A major component of paired helical filaments is abnormally hyperphosphorylated tau- Tangles are not specific to AD, being found in

other degenerative diseases